3 min read

EverHint – Undervalued V2 (Multi-Factor) – Top 10 Signals for Oct 23, 2026

10 signals. Energy leads (3). price range $4-$172.

Excerpt: 10 signals. Energy leads (3). price range $4-$172.

What This Signal Is

Identifies fundamentally undervalued stocks using a four-layer scoring system that combines value metrics, financial safety indicators, and catalyst signals. Produces a daily ranked list of the top N most undervalued stocks with a composite score from 0-100.

Entry Criteria:

  • Earnings Yield > sector average
  • Free Cash Flow Yield > 0
  • Piotroski F-Score ≥ 5
  • Altman Z-Score > 1.8
  • ROIC > 0
  • Debt/Equity < 3
  • Income Quality > 0.5
  • Market Cap ≥ $500M

Holding period: 3-12 months | Risk level: Medium-Low

Market Context

Broad equity markets are showing moderate weakness across all three major indices, with the Dow Jones leading the decline at -1.23%, suggesting larger-cap, value-oriented names are facing more selling pressure than growth-heavy counterparts. The relatively milder pullback in the Nasdaq (-0.21%) indicates that while risk appetite is softening, it hasn't fully collapsed. For undervalued strategies like undervalued_v2, this kind of divergence can create favorable entry conditions — value names that have already been under pressure may be reaching attractive levels without the broader market entering a full risk-off spiral.

The VIX at 19.45 with a +2.21% daily jump is worth monitoring closely. While still below the 20 threshold that typically signals elevated fear, the upward momentum in volatility suggests intraday price swings are widening. This environment can work both for and against value-based signals — wider spreads between intrinsic value and market price can strengthen the signal thesis, but increased volatility also raises execution risk and can delay the reversion that undervalued strategies depend on.

Energy's emergence as the top sector among today's signals aligns well with the current backdrop. Energy tends to exhibit defensive characteristics during periods of mild market stress while also benefiting from commodity-driven tailwinds independent of broader equity sentiment. With sector rotation appearing to favor more tangible, asset-backed industries over momentum plays, energy-focused undervalued signals may find a more receptive market environment for mean reversion over the near term.

📊 Signals (10 of 10 total)

Ranked by composite score (higher = more undervalued + safer + stronger catalysts)

# Ticker Company Sector Price Score MCap
1 STNG Scorpio Tankers Inc. Energy $85.92 80.35 $4.3B
2 TK Teekay Corporation Energy $14.72 73.42 $1.3B
3 NMM Navios Maritime Partne... Industrials $89.37 72.86 $2.5B
4 FSLR First Solar, Inc. Technology $171.99 72.09 $18.5B
5 MOMO Hello Group Inc. Communication Services $4.50 71.88 $646M
6 CRTO Criteo S.A. Communication Services $14.88 71.44 $729M
7 CRCT Cricut, Inc. Technology $6.25 70.60 $1.3B
8 SBC SBC Medical Group Hold... Industrials $5.28 69.93 $543M
9 PARR Par Pacific Holdings, ... Energy $77.15 69.84 $3.9B
10 KGC Kinross Gold Corporation Basic Materials $22.34 69.61 $26.5B

Recent Headlines

FSLR (First Solar, Inc.)

  • First Solar (FSLR) Declines More Than Market: Some Information for Investors
  • First Solar (FSLR) Earnings Expected to Grow: Should You Buy?
  • First Solar, Inc. (FSLR) Is a Trending Stock: Facts to Know Before Betting on It
  • First Solar shares may move 7.7% on earnings release

KGC (Kinross Gold Corporation)

  • Kinross Gold Corp stock hits 52-week low at 21.87 USD
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kinross Gold Corporation - KGC
  • 101,550 Shares in Kinross Gold Corporation $KGC Bought by Cantor Fitzgerald Investment Advisors L.P.

PARR (Par Pacific Holdings, Inc.)

  • Why Par Petroleum (PARR) is a Top Growth Stock for the Long-Term

SBC (SBC Medical Group Holdings Incorporated)

  • SBC Medical Initiates Development of a DNA Methylation Test to Estimate Biological Age

STNG (Scorpio Tankers Inc.)

  • Why Scorpio Tankers (STNG) is a Top Momentum Stock for the Long-Term

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.